Key result
Indobufen completely inhibits ex vivo secondary platelet aggregation and thromboxane B2 production in healthy volunteers.
Why the study?
Does indobufen inhibit platelet aggregation, the release reaction, and thromboxane B2 production in normal volunteers?
Does indobufen inhibit platelet aggregation, the release reaction, and thromboxane B2 production in normal volunteers?
Indobufen effectively inhibits platelet aggregation and the release reaction by blocking the platelet arachidonate pathway.
Answers are grounded in this paper and cite their sources.
Indobufen inhibits platelet function ex vivo in volunteers; hypothesis-generating for antithrombotic effects, requiring clinical outcome trials.
We have done a comprehensive study in normal volunteers of the in vitro and ex vivo effects of the antiplatelet agent indobufen on platelet aggregation, the release reaction and thromboxane B2 (TxB2) production as induced by different concentrations of aggregating agents. At low concentrations (10 microM), indobufen completely inhibited secondary platelet aggregation, the release reaction and TxB2 production stimulated by ADP, epinephrine and low concentrations of platelet-activating factor (PAF acether). Higher concentrations of indobufen (100 microM) completely inhibited TxB2 production, platelet aggregation and ATP release induced by arachidonic acid (1 mM) or collagen (2 micrograms/ml). The inhibitory effect was partially overcome by higher concentrations of arachidonic acid (2 mM). Data obtained ex vivo 2 h after the oral administration of 200 mg indobufen to 8 normal volunteers were in keeping with those of the in vitro study. We conclude that indobufen inhibits platelet aggregation and the release reaction by inhibiting the platelet arachidonate pathway.
No takes yet. Share an insight, caveat, or question.
Cattaneo et al. (2009) studied Healthy volunteers (n=8). Indobufen was evaluated on Platelet aggregation, release reaction and thromboxane B2 production. Indobufen completely inhibited secondary platelet aggregation, the release reaction, and thromboxane B2 production ex vivo in 8 normal volunteers.
Synapse has enriched 10 related papers. Consider them for comparative context: